- $556.77m
- $726.38m
- $294.48m
- 75
- 61
- 49
- 65
2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 303 | 331 | 387 | 328 | 294 |
Cost of Revenue | |||||
Gross Profit | 204 | 223 | 286 | 231 | 199 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 292 | 309 | 327 | 512 | 322 |
Operating Profit | 10.9 | 22.4 | 60.6 | -184 | -27.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.2 | -23 | 48.3 | -199 | -36.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 100 | -18.3 | 45.9 | -311 | -56.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 100 | -18.3 | 45.9 | -311 | -56.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 100 | -18.3 | 45.9 | -311 | -56.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.21 | -0.209 | 1.29 | -4.24 | -1.21 |